A detailed history of Alaethes Wealth LLC transactions in Novo Nordisk A S stock. As of the latest transaction made, Alaethes Wealth LLC holds 24,666 shares of NVO stock, worth $2.51 Million. This represents 1.13% of its overall portfolio holdings.

Number of Shares
24,666
Previous 24,293 1.54%
Holding current value
$2.51 Million
Previous $3.47 Million 15.32%
% of portfolio
1.13%
Previous 1.47%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$119.07 - $145.42 $44,413 - $54,241
373 Added 1.54%
24,666 $2.94 Million
Q2 2024

Aug 13, 2024

BUY
$122.71 - $146.91 $41,230 - $49,361
336 Added 1.4%
24,293 $3.47 Million
Q1 2024

May 15, 2024

BUY
$102.11 - $135.92 $155,615 - $207,142
1,524 Added 6.79%
23,957 $3.08 Million
Q4 2023

Feb 12, 2024

BUY
$87.78 - $105.45 $40,378 - $48,507
460 Added 2.09%
22,433 $2.32 Million
Q3 2023

Nov 13, 2023

BUY
$90.94 - $199.54 $1.08 Million - $2.37 Million
11,881 Added 117.73%
21,973 $2 Million
Q2 2023

Aug 14, 2023

SELL
$155.98 - $172.65 $65,511 - $72,513
-420 Reduced 4.0%
10,092 $1.63 Million
Q1 2023

May 15, 2023

BUY
$132.34 - $159.14 $51,347 - $61,746
388 Added 3.83%
10,512 $1.67 Million
Q4 2022

Feb 13, 2023

BUY
$102.55 - $135.33 $10,665 - $14,074
104 Added 1.04%
10,124 $1.37 Million
Q3 2022

Nov 14, 2022

BUY
$95.28 - $116.93 $47,449 - $58,231
498 Added 5.23%
10,020 $998,000
Q2 2022

Aug 16, 2022

BUY
$103.24 - $121.81 $47,903 - $56,519
464 Added 5.12%
9,522 $1.06 Million
Q1 2022

May 16, 2022

BUY
$93.1 - $112.54 $127,640 - $154,292
1,371 Added 17.84%
9,058 $1.01 Million
Q4 2021

Feb 15, 2022

BUY
$95.88 - $117.08 $737,029 - $899,993
7,687 New
7,687 $861,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $230B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Alaethes Wealth LLC Portfolio

Follow Alaethes Wealth LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alaethes Wealth LLC, based on Form 13F filings with the SEC.

News

Stay updated on Alaethes Wealth LLC with notifications on news.